VectivBio Appoints Patrick Malloy as Senior Vice President, Investor Relations & Strategic Communications
April 21, 2022 07:15 ET
|
VectivBio AG
BASEL, Switzerland, April 21, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for...
VectivBio Publishes Invitation to the Extraordinary General Meeting
August 12, 2021 07:15 ET
|
VectivBio AG
BASEL, Switzerland, Aug. 12, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company focused on the discovery, development and...
VectivBio Nominates Paul R. Carter and Murray W. Stewart for Election to its Board of Directors
July 12, 2021 07:15 ET
|
VectivBio AG
- Industry veterans bring decades of clinical, regulatory and commercial management expertise to VectivBio - - Nominees will stand for election at an Extraordinary General Meeting of shareholders on...